MedPath

Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer

Recruiting
Conditions
Spread Through Air Space
Non-small Cell Lung Cancer
Visceral Pleural Invasion
Lymphovascular Invasion
Registration Number
NCT05925738
Lead Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Brief Summary

The purpose of this study is to evaluate the performance of a PET/ CT-based deep learning signature for predicting aggressive histological pattern in resected non-small cell lung cancer based on a multicenter prospective cohort.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1500
Inclusion Criteria

(1) Participants scheduled for surgery for radiological finding of pulmonary lesions from the preoperative thin-section CT scans; (2) Pathological confirmation of primary NSCLC; (3) Age ranging from 20-75 years; (4) Obtained written informed consent.

Exclusion Criteria

(1) Multiple lung lesions; (2) Poor quality of PET-CT images; (3) Participants with incomplete clinical information; (4) Participants who have received neoadjuvant therapy.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Area under the receiver operating characteristic curve2023.5.1-2023.10.31

The area under the receiver operating characteristic curve (ROC) of the deep learning model in predicting the presence or absence of the aggressive histological pattern. The aggressive histological pattern includes spread through air space (STAS), visceral pleural invasion (VPI), and lymphovascular invasion (LVI). And the model will output all predictive values (presence or absence) of the three kinds of aggressive histological patterns.

Secondary Outcome Measures
NameTimeMethod
Sensitivity2023.5.1-2023.10.31

The sensitivity of the deep learning model in predicting the presence or absence of the aggressive histological pattern. The aggressive histological pattern includes spread through air space (STAS), visceral pleural invasion (VPI), and lymphovascular invasion (LVI). And the model will output all predictive values (presence or absence) of the three kinds of aggressive histological patterns.

Trial Locations

Locations (3)

Affiliated Hospital of Zunyi Medical University

🇨🇳

Zunyi, Guizhou, China

The First Affiliated Hospital of Nanchang University

🇨🇳

Nanchang, Jiangxi, China

Ningbo HwaMei Hospital

🇨🇳

Ningbo, Zhejiang, China

Affiliated Hospital of Zunyi Medical University
🇨🇳Zunyi, Guizhou, China
© Copyright 2025. All Rights Reserved by MedPath